In Vivo Imaging of β-Amyloid Plaques in Alzheimer's Disease Brains.
阿尔茨海默病大脑中 β-淀粉样斑块的体内成像。
基本信息
- 批准号:15390014
- 负责人:
- 金额:$ 7.49万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Formation and accumulation of β-amyloid (Aβ) peptide aggregates in the brain are critical factors in the development and progression of Alzheimer's disease (AD). In vivo imaging of amyloid plaques may lead to early detection of AD and monitoring the progression and effectiveness of AD treatment. In vivo imaging probes, showing high binding affinity for Aβ aggregates, and high brain penetrations, are essential for imaging of amyloid plaques in Alzheimer's disease. Recently, many agents based on Congo red and thioflavin have been reported as potential imaging agents. We have synthesized and evaluated benzofuran and stilbene derivatives labeled with ^<123>I and ^<11>C as PET and SPECT probes for imaging amyloid plaques in Alzheimer's disease. The results has prompted us to further search for effective and more practical amyloid imaging probe having a noble core structure.It has been previously shown that some flavones may have binding affinity to amyloid plaques in research into the mecha … More nism behind the anti-amyloidogenic activity of flavones. In this study, a series of flavone derivatives was designed and synthesized. Preparation of radioiodinated flavone was carried out by an iododestannylation reaction catalyzed by hydrogen peroxide. The log PC value of these flavones varied from 1.9 to 2.7, spanning the optimum range. The binding affinities for amyloid plaques were assessed by in vitro binding assay using pre-formed synthetic Aβ aggregates. The binding affinities of some compounds for Aβ (1-40) and Aβ (1-42) aggregates varied from 13nM to 77nM. When in vitro plaque labeling was carried out using post-mortem AD brain sections, all flavones intensely stained not only, amyloid plaques, but also cerebrovascular amyloids. The in vivo pharmacokinetic properties of radioiodinated flavone derivatives were evaluated in normal mice with standard biodistribution studies. Several compounds displayed high brain uptakes ranging from 3.2 to 4.1%ID/g at 2min post injection. The radioactivity was washed out from the brain rapidly (0.5-1.9%ID/g at 30min), which is highly desirable for amyloid imaging agents. These results suggest that the classes of radioiodinated flavones may be useful candidates as potential imaging agents for amyloid plaques. Less
大脑中β-淀粉样蛋白(Aβ)胡椒骨料的形成和积累是阿尔茨海默氏病(AD)发展和发展的关键因素。淀粉样蛋白斑块的体内成像可能会导致AD的早期检测并监测AD治疗的进展和有效性。体内成像问题,表现出对Aβ聚集体的高结合亲和力以及脑渗透高的亲和力,对于阿尔茨海默氏病淀粉样蛋白斑块的成像至关重要。最近,许多基于刚果红和硫牛素的药物被报道为潜在的成像剂。我们已经合成并评估了标记为 ^<123> i和 ^<11> c的苯并富龙和硅衍生物为PET,以及在阿尔茨海默氏病中成像淀粉样蛋白斑块的SPECT问题。结果促使我们进一步寻找具有崇高核心结构的有效且更实用的淀粉样蛋白成像探针。以前已经证明,某些黄酮在对机甲的研究中可能具有与淀粉样蛋白斑的结合亲和力……在抗淀粉样蛋白的抗淀粉样生殖活性背后的更多NISM。在这项研究中,设计和合成了一系列黄酮衍生物。放射性置的黄酮的制备是通过通过过氧化氢催化的碘植氨酸反应进行的。这些黄酮的日志PC值从1.9到2.7不等,涵盖了最佳范围。通过使用预形成的合成Aβ聚集体进行体外结合测定法评估了淀粉样蛋白斑块的结合亲和力。 Aβ(1-40)和Aβ(1-42)聚集体的某些化合物的结合亲和力从13nm到77nm不等。当使用验尸后的脑部切片进行体外斑块标记时,所有黄酮不仅染色,不仅染色,而且淀粉样蛋白斑块,而且染色。通过标准的生物分布研究,在正常小鼠中评估了放射性结合黄酮衍生物的体内药代动力学特性。注射后2分钟时,几种化合物显示出高脑摄取范围为3.2至4.1%/g。放射性迅速从大脑中冲出(30分钟时ID/G 0.5-1.9%),这对于淀粉样蛋白成像剂非常可取。这些结果表明,放射性约束的黄酮类可能是有用的候选物,作为淀粉样蛋白斑块的潜在成像剂。较少的
项目成果
期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Akizawa Hiromichi: "Effect of carboxylation of N-terminal phenylalanine of ^<111>In-DTPA (diethylenetri aminepentaacetic acid)-octreotide on accumulation of radioactivity in kidney"Biological & Pharmaceutical Bulletin. 27・2. 271-272 (2004)
Hiromichi Akizawa:“^<111>In-DTPA(二亚乙基三胺五乙酸)-奥曲肽的 N 末端苯丙氨酸的羧化对肾脏中放射性蓄积的影响”《生物与制药通报》27・2(2004)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Uehara Tomoya: "In vivo recognition of cyclopentadienyltricarbonylrhenium (CpTR) derivatives"Nuclear Medicine and Biol. 30. 327-333 (2003)
上原朋也:“环戊二烯基三羰基铼(CpTR)衍生物的体内识别”核医学与生物学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tc^^99m-labeled mannosyl-neoglycoalbumin for sentinel lymph node identification.
Tc^^99m 标记的甘露糖基新糖白蛋白用于前哨淋巴结鉴定。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:K.Takagi;T.Uehara;E.Kaneko;M.Nakayama;M.Kizumi;K.Endo;Y.Arano
- 通讯作者:Y.Arano
Synthesis and biological evaluation of (E)-3-styrylpyridine derives as amyloid imaging agents for Alzheimer's disease.
(E)-3-苯乙烯基吡啶的合成和生物学评价作为阿尔茨海默病的淀粉样蛋白显像剂。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:M.Ono;M.Hatarake;M.Nakayama;K.Kawabata;H.Mori;M-P.Kung;H.F.Kung
- 通讯作者:H.F.Kung
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAKAYAMA Morio其他文献
NAKAYAMA Morio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAKAYAMA Morio', 18)}}的其他基金
Development of multimodal imaging probes targeting survivin.
开发针对生存素的多模态成像探针。
- 批准号:
16K15585 - 财政年份:2016
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of a unified producing system for various 68Ga-radiopharmaceuticals based on the characteristics of novel 68Ge/68Ga generator.
基于新型68Ge/68Ga发生器的特点,开发了多种68Ga放射性药物的统一生产系统。
- 批准号:
16H05392 - 财政年份:2016
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of molecular probe for SPECT imaging of amyloid in the brain
开发脑部淀粉样蛋白 SPECT 成像分子探针
- 批准号:
21390348 - 财政年份:2009
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of production-system of PET imaging agents without cyclotron.
开发无回旋加速器的PET显像剂生产系统。
- 批准号:
18390015 - 财政年份:2006
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Construction of lipid bilayer membrane on ion-exchange resin surface and the application as separation material
离子交换树脂表面脂质双层膜的构建及其作为分离材料的应用
- 批准号:
11672146 - 财政年份:1999
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of ^<99m>Tc-complexes for imaging cancer metastasis
用于癌症转移成像的^<99m>Tc复合物的开发
- 批准号:
09672190 - 财政年份:1997
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Preparation of ^<99m>Tc radiopharmaceuticals using macroreticular Sn (II) complex
大网状Sn(II)络合物制备^<99m>Tc放射性药物
- 批准号:
04557104 - 财政年份:1992
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Developement of New Polymer Membranes for Separation
新型聚合物分离膜的开发
- 批准号:
60550644 - 财政年份:1985
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
氧敏感MRI分子成像评价HIF1α-VEGF信号通路诱导糖尿病心肌缺氧损伤及微循环障碍的机制研究
- 批准号:82371925
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于血行转移芯片的Wnt通路关键调控分子实时成像及其调控肿瘤转移的协同作用研究
- 批准号:22374016
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于超高局域等离激元场动量分布的聚乙炔链分子拉曼成像理论及应用研究
- 批准号:22373060
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
三光子荧光活体探针用于阿兹海默症脑血管成像诊断
- 批准号:52372271
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于多色电化学发光成像的单分子计数新方法及外泌体蛋白质多元分析
- 批准号:22304146
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Quantitative imaging of choroid plexus function and neurofluid circulation in Alzheimer's Disease Related Dementia
阿尔茨海默病相关痴呆症脉络丛功能和神经液循环的定量成像
- 批准号:
10718346 - 财政年份:2023
- 资助金额:
$ 7.49万 - 项目类别:
Multimodal imaging measures to assess synaptic dysfunction in Alzheimer's disease
评估阿尔茨海默病突触功能障碍的多模态成像方法
- 批准号:
10448946 - 财政年份:2022
- 资助金额:
$ 7.49万 - 项目类别:
Investigating the Temperature Dependence of Age-related Tau Pathology Relevant to Early Alzheimer's Disease
研究与早期阿尔茨海默病相关的年龄相关 Tau 病理学的温度依赖性
- 批准号:
10612943 - 财政年份:2021
- 资助金额:
$ 7.49万 - 项目类别:
Imaging brain iron and protein aggregation with MRI for assessing Alzheimer's disease pathology and progression
使用 MRI 对脑铁和蛋白质聚集进行成像,以评估阿尔茨海默病的病理学和进展
- 批准号:
10563181 - 财政年份:2021
- 资助金额:
$ 7.49万 - 项目类别:
Association of blood-brain barrier breakdown with brain microstructure neuropathology in early Alzheimer's Disease
早期阿尔茨海默病中血脑屏障破坏与脑微结构神经病理学的关联
- 批准号:
10469657 - 财政年份:2021
- 资助金额:
$ 7.49万 - 项目类别: